Data through FY2026 Q3 (Jun 30, 2026)
Mersana Therapeutics, Inc.
Company profile for Mersana Therapeutics, Inc. covers 4 filings across the reporting window. No certified median available for FY2026.
- FY2026 certified median
- Unavailable
- Total filings
- 4
- FY2026 25th–75th percentile
- Unavailable
- Top job title
- Associate Director- New Product Strategy
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 2 | $115,638 | $112,819 | $118,456 |
| FY2026 (Q1–Q3) | 2 | Unavailable | Unavailable | Unavailable |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Associate Director- New Product Strategy1 filings
- Principal Associate Scientist, Analytical Chemistry1 filings
- Principal Associate Scientist, Biology/Immuno-Oncology1 filings
- Senior Associate Scientist, Biology/Immuno-Oncology1 filings
Top cities
- Cambridge4 filings